Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

publishing date : 2021 - 12 - 14    tags : Europe    save search

Ascendis Pharma A/S Virtual R&D Program Update Highlights Continued Development Across R&D Pipeline
Published: 2021-12-14 (Crawled : 15:30) - biospace.com/
ASND | $143.18 -1.14% -1.18% 240K twitter stocktwits trandingview |
Health Technology
| | O: -0.56% H: 2.19% C: -1.93%

pharma
EPAM Acquires Optiva Media, Expanding Presence in Western Europe & Latin America
Published: 2021-12-14 (Crawled : 15:30) - prnewswire.com
FNCTF | News | $11.16 1.13% -20.84% 0 twitter stocktwits trandingview |
Communications
| | O: 1.65% H: 0.0% C: -1.39%
EPAM | $245.0 -1.13% -0.12% 700K twitter stocktwits trandingview |
Technology Services
| | O: -1.46% H: 0.64% C: -1.76%

europe media
Mainstay Medical Announces Appointment of Jeffrey Dunn and Eric Major to its Board of Directors
Published: 2021-12-14 (Crawled : 13:30) - biospace.com/
SYK | $336.85 0.58% 0.93% 1.2M twitter stocktwits trandingview |
Health Technology
| | O: -0.77% H: 0.39% C: -1.36%
SIBN | $15.08 -1.24% -1.19% 380K twitter stocktwits trandingview |
Health Technology
| | O: -0.05% H: 2.56% C: 0.4%


Chinook Therapeutics Receives Orphan Drug Designation from European Commission for Atrasentan for Treatment of Primary IgA Nephropathy
Published: 2021-12-14 (Crawled : 13:30) - biospace.com/
KDNY | $40.39 0.22% -0.17% 0 twitter stocktwits trandingview |
Health Technology
| | O: -3.4% H: 1.94% C: -4.85%

treatment europe nephropathy drug therapeutics orphan drug designation
Alnylam Submits Regulatory Applications to the U.S. Food and Drug Administration and European Medicines Agency to Support Label Expansion for OXLUMO® for the Treatment of Advanced Primary Hyperoxaluria Type 1
Published: 2021-12-14 (Crawled : 12:30) - biospace.com/
SNYNF | News | $94.0 -0.27% -2.18% 0 twitter stocktwits trandingview |
Health Technology
| | O: -3.62% H: 0.0% C: -0.56%
SNY | News | $46.61 -2.27% -2.21% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: -0.51% H: 0.0% C: 0.0%
ALNY | $143.8 -1.55% -1.58% 400K twitter stocktwits trandingview |
Health Technology
| | O: 6.02% H: 2.03% C: -0.29%

oxlumo treatment europe application expansion drug food
32% of Growth to Originate from North America for Pharmaceutical Caps and Closures Market | By Material (plastic, metal, and rubber or cork) and Geography (North America, Europe, APAC, South America, and MEA) | 2021-2025 Analysis and Review | Technavio
Published: 2021-12-14 (Crawled : 11:00) - prnewswire.com
AMCR | $9.06 0.89% 1.55% 4.3M twitter stocktwits trandingview |
Process Industries
| | O: 0.56% H: 0.0% C: 0.0%
SLGN | $47.32 0.19% 0.0% 510K twitter stocktwits trandingview |
Process Industries
| | O: -2.21% H: 0.91% C: 0.36%

europe growth
Mainz Biomed Expands ColoAlert Commercialization with GANZIMMUN Diagnostics in Europe
Published: 2021-12-14 (Crawled : 09:00) - globenewswire.com
MYNZ | $0.8987 3.42% 3.34% 5.6K twitter stocktwits trandingview |
| | O: -7.14% H: 1.49% C: -5.34%

diagnostic commercialization europe diagnostics
Gainers vs Losers
61% 39%

Top 10 Gainers
BOF | $2.08 77.78% 39.06% 110M twitter stocktwits trandingview |

BHIL | $0.1793 -4.37% 19.24% 340K twitter stocktwits trandingview |
Agriculture, Forestry, Fishing ...

UMAC | $1.48 -1.33% 14.87% 20K twitter stocktwits trandingview |

CI | $352.28 -0.11% 13.53% 2 twitter stocktwits trandingview |
Health Services

CIG.C | $2.89 -1.37% 12.8% 2.3K twitter stocktwits trandingview |
n/a

BMTX 4 | $1.545 0.98% 10.03% 2.5K twitter stocktwits trandingview |
Information

TAL | $12.26 0.57% 9.22% 12M twitter stocktwits trandingview |
Consumer Services

MTH | $154.69 -2.21% 7.56% 64 twitter stocktwits trandingview |
Consumer Durables

ASXC | $0.243 -2.41% 7.0% 1.1M twitter stocktwits trandingview |
Manufacturing

NYC 4 | $6.03 1.86% 6.8% 0 twitter stocktwits trandingview |
Finance


Your saved searches
Save your searches and get alerts when important news are released.